Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Azacitidine
Acute Erythroid Leukemia
Nanfang Hospital, Southern Medical University
P2
BB
(66)
Carboplatin
Follicular Lymphoma
David Bond, MD
P2
BB
(66)
Carboplatin
Sarcoma
OHSU Knight Cancer Institute
P2
BB
(66)
Carboplatin
Urinary Bladder Neoplasm
Merck Sharp & Dohme LLC
P2
BB
(66)
Cediranib
Brain Cancer
National Cancer Institute (NCI)
P2
BB
(66)
Cediranib
Mycosis Fungoides
National Cancer Institute (NCI)
P2
BB
(66)
Cis-Diamminedichloroplatinum Ii
Malignant Pleural Mesothelioma
AstraZeneca
P2
BB
(66)
Cis-Diamminedichloroplatinum Ii
Sarcoma
Roswell Park Cancer Institute
P2
BB
(66)
Cyclophosphamide
Prostate Adenocarcinoma
Beijing Biotech
P2
BB
(66)
Cyclophosphamide
Estrogen-Receptor Positive Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P2
BB
(66)
Cyclophosphamide
Indolent B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P2
BB
(66)
Cyclophosphamide
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical Center
P2
BB
(66)
Cyclophosphamide
Ovarian Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(66)
Cyclophosphamide
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P2
BB
(66)
Cyclophosphamide
Fallopian Tube Carcinoma
Mayo Clinic
P2
BB
(66)
Cyclophosphamide
Small Intestine Cancer
National Cancer Institute (NCI)
P2
BB
(66)
Cyclosporin A
Anaplastic Large Cell Lymphoma
Fred Hutchinson Cancer Center
P2
BB
(66)
Cyclosporin A
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer Center
P2
BB
(66)
Cytarabine
Acute Biphenotypic Leukemia
University of Washington
P2
BB
(66)
Dexasone
Nodal Marginal Zone B-Cell Lymphoma
Izidore Lossos, MD
P2
BB
(66)
Dexasone
Splenic Marginal Zone Lymphoma
Izidore Lossos, MD
P2
BB
(66)
Dexasone
Waldenstrom Macroglobulinemia
Christian Buske
P2
BB
(66)
Durvalumab
Ovarian Carcinoma
AGO Research GmbH
P2
BB
(66)
Durvalumab
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P2
BB
(66)
Epirubicin
Estrogen-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BB
(66)
Showing 2376 to 2400 of 42,301 assets
Previous
Page 96 of 1693
Next